Bioethics News

Theranos CEO Holmes Barred from Operating Lab for 2 Years

July 8, 2016

(Reuters) – A U.S. health regulator has barred blood-testing company Theranos Inc’s founder and CEO, Elizabeth Holmes, from operating a lab for at least two years, the latest blow for a company that is under scrutiny for the accuracy and quality of its tests. The Centers for Medicare & Medicaid Services (CMS)revoked a key certificate for the company’s Newark, California lab, and terminated the facility’s approval to receive Medicare and Medicaid payments for all services, Theranos said late on Thursday.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.